APA (7th ed.) Citation

K, A., T, S., A, K., S, H., T, K., S, T., . . . H, A. (2009). Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation. Cancer Chemotherapy & Pharmacology, 64(3), 565. https://doi.org/10.1007/s00280-008-0907-3

Chicago Style (17th ed.) Citation

K, Azuma, et al. "Expression of ERCC1 and Class III Beta-tubulin in Non-small Cell Lung Cancer Patients Treated with a Combination of Cisplatin/docetaxel and Concurrent Thoracic Irradiation." Cancer Chemotherapy & Pharmacology 64, no. 3 (2009): 565. https://doi.org/10.1007/s00280-008-0907-3.

MLA (9th ed.) Citation

K, Azuma, et al. "Expression of ERCC1 and Class III Beta-tubulin in Non-small Cell Lung Cancer Patients Treated with a Combination of Cisplatin/docetaxel and Concurrent Thoracic Irradiation." Cancer Chemotherapy & Pharmacology, vol. 64, no. 3, 2009, p. 565, https://doi.org/10.1007/s00280-008-0907-3.